Last 12 months
Inside the activity.
12 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 8 | 2 |
| Dec 2025 | 4 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2020 Filed Oct 5, 2020 23:00 UTC |
Chen RichardChief Scientific Officer
|
SaleCommon Stock | 26,528 | $22.26 | $590,513.28 |
DisclosureSEC source: 0001209191-20-053885 · doc4.xml · nonDerivative · entry 3 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,750 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The weighted average sale price for the transaction reported was $22.26, and the range of prices was between $22.10 and $22.54. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 23:00 UTC |
Chen RichardChief Scientific Officer
|
SaleCommon Stock | 13,472 | $21.67 | $291,938.24 |
DisclosureSEC source: 0001209191-20-053885 · doc4.xml · nonDerivative · entry 2 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,278 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The weighted average sale price for the transaction reported was $21.67, and the range of prices was between $21.03 and $22.02. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 23:00 UTC |
Chen RichardChief Scientific Officer
|
Exercise / conversionCommon Stock | 37,452 | $0.44 | $16,478.88 |
DisclosureSEC source: 0001209191-20-053885 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2020 Filed Sep 21, 2020 23:03 UTC |
Tachibana AaronChief Financial Officer
|
SaleCommon Stock | 2,463 | $22.74 | $56,008.62 |
DisclosureSEC source: 0001209191-20-051371 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,608 F1 · kind: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| September 17, 2020 Filed Sep 21, 2020 23:05 UTC |
Chen RichardChief Scientific Officer
|
SaleCommon Stock | 1,120 | $22.74 | $25,468.80 |
DisclosureSEC source: 0001209191-20-051372 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,298 F1 · kind: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 22:41 UTC |
Tachibana AaronChief Financial Officer
|
SaleCommon Stock | 2,899 | $22.99 | $66,648.01 |
DisclosureSEC source: 0001209191-20-049658 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,071 F1 · kind: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 22:39 UTC |
Chen RichardChief Scientific Officer
|
SaleCommon Stock | 291 | $22.99 | $6,690.09 |
DisclosureSEC source: 0001209191-20-049655 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,418 F1 · kind: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| August 18, 2020 Filed Aug 20, 2020 20:00 UTC |
Abingworth LLP10% owner
|
SaleCommon Stock, $0.0001 par value per share | 986,842 | $19.00 | $18,749,998.00 |
DisclosureSEC source: 0000905718-20-000875 · ownership.xml · nonDerivative · entry 1 Abingworth LLP · CIK 0001397144 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,462,452 F1 · ownership.nature: The shares are held by Abingworth Bioventures V LP ("Abingworth V"). Abingworth Bioventures V GP LP ("Abingworth GP") serves as the general partner of Abingworth V. Abingworth General Partner V LLP, serves as the general partner of Abingworth GP. Abingworth V (acting by its general partner Abingworth GP, acting by its general partner Abingworth General Partner V LLP) has delegated to Abingworth LLP ("ALLP"), all investment and dispositive power over the securities held by Abingworth V. ALLP holds the reported securities indirectly through Abingworth V. ALLP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that the reporting person, Abingworth V or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Read SEC document |
| August 14, 2020 Filed Aug 18, 2020 17:01 UTC |
Lightspeed Venture Partners Select IV, L.P.Affiliate of 10% Owner
Liew JeremyAffiliate of 10% Owner
Mhatre RaviAffiliate of 10% Owner
Lightspeed General Partner Select IV, L.P.Affiliate of 10% Owner
Lightspeed Ultimate General Partner Select IV, L.L.C.Affiliate of 10% Owner
Janmohamed ArifAffiliate of 10% Owner
|
PurchaseCommon Stock | 1,315,789 | $19.00 | $24,999,991.00 |
DisclosureSEC source: 0001209191-20-047228 · doc4.xml · nonDerivative · entry 1 Lightspeed Venture Partners Select IV, L.P. · CIK 0001805207 · Affiliate of 10% Owner Liew Jeremy · CIK 0001700539 · Affiliate of 10% Owner Mhatre Ravi · CIK 0001366050 · Affiliate of 10% Owner Lightspeed General Partner Select IV, L.P. · CIK 0001813995 · Affiliate of 10% Owner Lightspeed Ultimate General Partner Select IV, L.L.C. · CIK 0001813999 · Affiliate of 10% Owner Janmohamed Arif · CIK 0001813938 · Affiliate of 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,774,240 F1 · ownership.direct: Shares held by Lightspeed Venture Partners Select IV, L.P. ("Lightspeed Select IV"). Lightspeed General Partner Select IV, L.P. ("LGP Select IV") is the general partner of Lightspeed Select IV. Lightspeed Ultimate General Partner Select IV, L.L.C. ("LUGP Select IV") is the general partner of LGP Select IV. Jeremy Liew, Ravi Mhatre and Arif Janmohamed are the managers of LUGP Select IV and share voting and dispositive power with respect to the shares held by Lightspeed Select IV. LGP Select IV, LUGP Select IV and Messrs. Liew, Mhatre and Janmohamed disclaim beneficial ownership of the shares held by Lightspeed Select IV except to the extent of their respective pecuniary interests therein. F1 · ownership.nature: Shares held by Lightspeed Venture Partners Select IV, L.P. ("Lightspeed Select IV"). Lightspeed General Partner Select IV, L.P. ("LGP Select IV") is the general partner of Lightspeed Select IV. Lightspeed Ultimate General Partner Select IV, L.L.C. ("LUGP Select IV") is the general partner of LGP Select IV. Jeremy Liew, Ravi Mhatre and Arif Janmohamed are the managers of LUGP Select IV and share voting and dispositive power with respect to the shares held by Lightspeed Select IV. LGP Select IV, LUGP Select IV and Messrs. Liew, Mhatre and Janmohamed disclaim beneficial ownership of the shares held by Lightspeed Select IV except to the extent of their respective pecuniary interests therein. Read SEC document |
| August 14, 2020 Filed Aug 18, 2020 21:35 UTC |
LUDLUM KENDirector
|
SaleCommon Stock | 6,470 | $20.42 | $132,117.40 |
DisclosureSEC source: 0001209191-20-047391 · doc4.xml · nonDerivative · entry 2 LUDLUM KEN · CIK 0001255825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The weighted average sale price for the transaction reported was $20.42, and the range of prices was between $20.40 and $20.48 per share. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 14, 2020 Filed Aug 18, 2020 21:35 UTC |
LUDLUM KENDirector
|
SaleCommon Stock | 13,530 | $20.05 | $271,276.50 |
DisclosureSEC source: 0001209191-20-047391 · doc4.xml · nonDerivative · entry 1 LUDLUM KEN · CIK 0001255825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,470 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The weighted average sale price for the transaction reported was $20.05, and the range of prices was between $19.40 and $20.39 per share. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 14, 2020 Filed Aug 19, 2020 01:47 UTC |
Chen RichardChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 653 | $0.00 Strike: $1.84 | $0.00 |
DisclosureSEC source: 0001209191-20-047402 · doc4.xml · derivative · entry 6 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,346 Underlying: Common Stock · 653 shares Expires 2023-11-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| August 14, 2020 Filed Aug 19, 2020 01:47 UTC |
Chen RichardChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 27,913 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001209191-20-047402 · doc4.xml · derivative · entry 5 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,336 Underlying: Common Stock · 27,913 shares Expires 2022-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| August 14, 2020 Filed Aug 19, 2020 01:47 UTC |
Chen RichardChief Scientific Officer
|
SaleCommon Stock | 1,200 | $20.47 | $24,564.00 |
DisclosureSEC source: 0001209191-20-047402 · doc4.xml · nonDerivative · entry 4 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,709 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan by the reporting person. F4 · price: The weighted average sale price for the transaction reported was $20.47, and the range of prices was between $20.45 to $20.48 per share. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 14, 2020 Filed Aug 19, 2020 01:47 UTC |
Chen RichardChief Scientific Officer
|
SaleCommon Stock | 27,366 | $20.17 | $551,972.22 |
DisclosureSEC source: 0001209191-20-047402 · doc4.xml · nonDerivative · entry 3 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,909 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan by the reporting person. F3 · price: The weighted average sale price for the transaction reported was $20.17, and the range of prices was between $19.45 to $20.44 per share. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 14, 2020 Filed Aug 19, 2020 01:47 UTC |
Chen RichardChief Scientific Officer
|
SaleCommon Stock | 3,434 | $19.76 | $67,855.84 |
DisclosureSEC source: 0001209191-20-047402 · doc4.xml · nonDerivative · entry 2 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,275 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan by the reporting person. F2 · price: The weighted average sales price for the transaction reported was $19.76, and the range of prices was between $19.36 and $20.18 per share. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| August 14, 2020 Filed Aug 19, 2020 01:47 UTC |
Chen RichardChief Scientific Officer
|
Exercise / conversionCommon Stock | 28,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-047402 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 21:48 UTC |
Chen RichardChief Scientific Officer
|
SaleCommon Stock | 1,085 | $12.37 | $13,421.45 |
DisclosureSEC source: 0001209191-20-038758 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,143 F1 · kind: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| June 05, 2020 Filed Jun 11, 2020 23:06 UTC Amendment |
Chen RichardChief Scientific Officer
|
SaleCommon Stock | 272 | $14.34 | $3,900.48 |
DisclosureSEC source: 0001209191-20-036075 · doc4a.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,228 F1 · kind: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| June 02, 2020 Filed Jun 3, 2020 17:00 UTC |
Lightspeed Venture Partners Select IV, L.P.Affiliate of 10% Owner
Liew JeremyAffiliate of 10% Owner
Mhatre RaviAffiliate of 10% Owner
Lightspeed General Partner Select IV, L.P.Affiliate of 10% Owner
Lightspeed Ultimate General Partner Select IV, L.L.C.Affiliate of 10% Owner
Janmohamed ArifAffiliate of 10% Owner
|
PurchaseCommon Stock | 380,654 | $13.98 | $5,321,542.92 |
DisclosureSEC source: 0001209191-20-034108 · doc4.xml · nonDerivative · entry 2 Lightspeed Venture Partners Select IV, L.P. · CIK 0001805207 · Affiliate of 10% Owner Liew Jeremy · CIK 0001700539 · Affiliate of 10% Owner Mhatre Ravi · CIK 0001366050 · Affiliate of 10% Owner Lightspeed General Partner Select IV, L.P. · CIK 0001813995 · Affiliate of 10% Owner Lightspeed Ultimate General Partner Select IV, L.L.C. · CIK 0001813999 · Affiliate of 10% Owner Janmohamed Arif · CIK 0001813938 · Affiliate of 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 458,451 F3 · price: This transaction was executed in multiple trades at prices ranging from $13.500 to $14.105. The price reported above reflects the weighted average price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.direct: Shares held by Lightspeed Venture Partners Select IV, L.P. ("Lightspeed Select IV"). Lightspeed General Partner Select IV, L.P. ("LGP Select IV") is the general partner of Lightspeed Select IV. Lightspeed Ultimate General Partner Select IV, L.L.C. ("LUGP Select IV") is the general partner of LGP Select IV. Jeremy Liew, Ravi Mhatre and Arif Janmohamed are the managers of LUGP Select IV and share voting and dispositive power with respect to the shares held by Lightspeed Select IV. LGP Select IV, LUGP Select IV and Messrs. Liew, Mhatre and Janmohamed disclaim beneficial ownership of the shares held by Lightspeed Select IV except to the extent of their respective pecuniary interests therein. F2 · ownership.nature: Shares held by Lightspeed Venture Partners Select IV, L.P. ("Lightspeed Select IV"). Lightspeed General Partner Select IV, L.P. ("LGP Select IV") is the general partner of Lightspeed Select IV. Lightspeed Ultimate General Partner Select IV, L.L.C. ("LUGP Select IV") is the general partner of LGP Select IV. Jeremy Liew, Ravi Mhatre and Arif Janmohamed are the managers of LUGP Select IV and share voting and dispositive power with respect to the shares held by Lightspeed Select IV. LGP Select IV, LUGP Select IV and Messrs. Liew, Mhatre and Janmohamed disclaim beneficial ownership of the shares held by Lightspeed Select IV except to the extent of their respective pecuniary interests therein. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 17:00 UTC |
Lightspeed Venture Partners Select IV, L.P.Affiliate of 10% Owner
Liew JeremyAffiliate of 10% Owner
Mhatre RaviAffiliate of 10% Owner
Lightspeed General Partner Select IV, L.P.Affiliate of 10% Owner
Lightspeed Ultimate General Partner Select IV, L.L.C.Affiliate of 10% Owner
Janmohamed ArifAffiliate of 10% Owner
|
PurchaseCommon Stock | 77,797 | $12.98 | $1,009,805.06 |
DisclosureSEC source: 0001209191-20-034108 · doc4.xml · nonDerivative · entry 1 Lightspeed Venture Partners Select IV, L.P. · CIK 0001805207 · Affiliate of 10% Owner Liew Jeremy · CIK 0001700539 · Affiliate of 10% Owner Mhatre Ravi · CIK 0001366050 · Affiliate of 10% Owner Lightspeed General Partner Select IV, L.P. · CIK 0001813995 · Affiliate of 10% Owner Lightspeed Ultimate General Partner Select IV, L.L.C. · CIK 0001813999 · Affiliate of 10% Owner Janmohamed Arif · CIK 0001813938 · Affiliate of 10% Owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 77,797 F1 · price: This transaction was executed in multiple trades at prices ranging from $12.62 to $13.43. The price reported above reflects the weighted average price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.direct: Shares held by Lightspeed Venture Partners Select IV, L.P. ("Lightspeed Select IV"). Lightspeed General Partner Select IV, L.P. ("LGP Select IV") is the general partner of Lightspeed Select IV. Lightspeed Ultimate General Partner Select IV, L.L.C. ("LUGP Select IV") is the general partner of LGP Select IV. Jeremy Liew, Ravi Mhatre and Arif Janmohamed are the managers of LUGP Select IV and share voting and dispositive power with respect to the shares held by Lightspeed Select IV. LGP Select IV, LUGP Select IV and Messrs. Liew, Mhatre and Janmohamed disclaim beneficial ownership of the shares held by Lightspeed Select IV except to the extent of their respective pecuniary interests therein. F2 · ownership.nature: Shares held by Lightspeed Venture Partners Select IV, L.P. ("Lightspeed Select IV"). Lightspeed General Partner Select IV, L.P. ("LGP Select IV") is the general partner of Lightspeed Select IV. Lightspeed Ultimate General Partner Select IV, L.L.C. ("LUGP Select IV") is the general partner of LGP Select IV. Jeremy Liew, Ravi Mhatre and Arif Janmohamed are the managers of LUGP Select IV and share voting and dispositive power with respect to the shares held by Lightspeed Select IV. LGP Select IV, LUGP Select IV and Messrs. Liew, Mhatre and Janmohamed disclaim beneficial ownership of the shares held by Lightspeed Select IV except to the extent of their respective pecuniary interests therein. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 23:21 UTC |
Chen RichardChief Scientific Officer
|
SaleCommon Stock | 289 | $13.19 | $3,811.91 |
DisclosureSEC source: 0001209191-20-034273 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,211 F1 · kind: Shares sold to cover tax obligation from settlement of vested restricted stock units. Read SEC document |
| May 15, 2020 Filed May 19, 2020 22:14 UTC |
BOWMAN A BLAINEDirector
|
GrantStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $11.22 | $0.00 |
DisclosureSEC source: 0001209191-20-030663 · doc4.xml · derivative · entry 1 BOWMAN A BLAINE · CIK 0001008891 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2030-05-14 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders. In the event of a change in control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such change in control. Read SEC document |
| May 15, 2020 Filed May 19, 2020 22:15 UTC |
BALTHROP PATRICK JDirector
|
GrantStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $11.22 | $0.00 |
DisclosureSEC source: 0001209191-20-030665 · doc4.xml · derivative · entry 1 BALTHROP PATRICK J · CIK 0001284839 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2030-05-14 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders. In the event of a change of control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such change in control. Read SEC document |
| May 15, 2020 Filed May 19, 2020 22:10 UTC |
EASTHAM KARINDirector
|
GrantStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $11.22 | $0.00 |
DisclosureSEC source: 0001209191-20-030651 · doc4.xml · derivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2030-05-14 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders. In the event of a change in control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such change in control. Read SEC document |
| May 15, 2020 Filed May 19, 2020 18:13 UTC |
RICCI PAULDirector
|
GrantStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $11.22 | $0.00 |
DisclosureSEC source: 0001209191-20-030660 · doc4.xml · derivative · entry 1 RICCI PAUL · CIK 0001218326 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2030-05-14 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders. In the event of a change in control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such change in control. Read SEC document |
| May 15, 2020 Filed May 19, 2020 18:12 UTC |
LUDLUM KENDirector
|
GrantStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $11.22 | $0.00 |
DisclosureSEC source: 0001209191-20-030657 · doc4.xml · derivative · entry 1 LUDLUM KEN · CIK 0001255825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2030-05-14 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders. In the event of a change in control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such change in control. Read SEC document |
| May 15, 2020 Filed May 19, 2020 18:11 UTC |
Colowick AlanDirector
|
GrantStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $11.22 | $0.00 |
DisclosureSEC source: 0001209191-20-030653 · doc4.xml · derivative · entry 1 Colowick Alan · CIK 0001316163 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2030-05-14 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders. In the event of a change in control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such change in control. Read SEC document |
| May 15, 2020 Filed May 19, 2020 22:12 UTC |
MacQuitty JonathanDirector
|
GrantStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $11.22 | $0.00 |
DisclosureSEC source: 0001209191-20-030655 · doc4.xml · derivative · entry 1 MacQuitty Jonathan · CIK 0001779844 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2030-05-14 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders. In the event of a change in control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such change in control. Read SEC document |
| March 27, 2020 Filed Mar 27, 2020 23:59 UTC |
Chen RichardChief Scientific Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001209191-20-021561 · doc4.xml · derivative · entry 4 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,249 Underlying: Common Stock · 15,000 shares Expires 2022-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| March 27, 2020 Filed Mar 27, 2020 23:59 UTC |
Chen RichardChief Scientific Officer
|
Exercise / conversionCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-021561 · doc4.xml · nonDerivative · entry 2 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 25, 2020 Filed Mar 27, 2020 23:59 UTC |
Chen RichardChief Scientific Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001209191-20-021561 · doc4.xml · derivative · entry 3 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,249 Underlying: Common Stock · 10,000 shares Expires 2022-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| March 25, 2020 Filed Mar 27, 2020 23:59 UTC |
Chen RichardChief Scientific Officer
|
Exercise / conversionCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-021561 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 21:45 UTC |
West John StephenDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 421,000 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0001209191-20-020365 · doc4.xml · derivative · entry 2 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 421,000 Underlying: Common Stock · 421,000 shares Expires 2030-03-16 F2 · derivative.exercise_date: The shares subject to the option will vest in full when the Company's market capitalization, calculated as the closing price of the Company's common stock on the Nasdaq Global Stock Market multiplied by the number of shares of the Company's common stock outstanding, averages over or equal to $1 billion over a 30 calendar day period. Upon a change in control, the vesting of the shares subject to the option will accelerate on a pro rata basis based on the price per share in such change in control transaction multiplied by the number of shares of the Company's common stock outstanding at the time of completion of such transaction divided by $1 billion, with up to 100% of the shares eligible for such accelerated vesting. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 21:45 UTC |
West John StephenDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 330,000 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0001209191-20-020365 · doc4.xml · derivative · entry 1 West John Stephen · CIK 0001779811 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 330,000 Underlying: Common Stock · 330,000 shares Expires 2030-03-16 F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments starting on April 17, 2020. Read SEC document |
| March 16, 2020 Filed Mar 19, 2020 00:43 UTC |
Tachibana AaronChief Financial Officer
|
GrantCommon Stock | 82,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-020139 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,970 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest in 16 equal quarterly installments with the first installment vesting on June 16, 2020. F2 · balance_after: Includes 1,470 shares acquired under the Issuer's Employee Stock Purchase Plan on November 1, 2019 which has been corrected from the prior Form 4 filed on December 3, 2019. Read SEC document |
| March 16, 2020 Filed Mar 19, 2020 00:43 UTC |
Tachibana AaronChief Financial Officer
|
GrantCommon Stock | 82,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-020138 · doc4.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,970 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest in 16 equal quarterly installments with the first installment vesting on June 16, 2020. F2 · balance_after: Includes 1,470 shares acquired under the Issuer's Employee Stock Purchase Plan on November 1, 2019 which has been corrected from the prior Form 4 filed on December 3, 2019. Read SEC document |
| March 16, 2020 Filed Mar 19, 2020 00:45 UTC |
Musil ClintonChief Business Officer
|
GrantCommon Stock (right to Buy) · Derivative | 11,000 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001209191-20-020141 · doc4.xml · derivative · entry 2 Musil Clinton · CIK 0001779886 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2030-03-16 F2 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 16, 2020. Read SEC document |
| March 16, 2020 Filed Mar 19, 2020 00:45 UTC |
Musil ClintonChief Business Officer
|
GrantCommon Stock | 11,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-020141 · doc4.xml · nonDerivative · entry 1 Musil Clinton · CIK 0001779886 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest in 16 equal quarterly installments with the first installment vesting on June 16, 2020. Read SEC document |
| March 16, 2020 Filed Mar 19, 2020 00:44 UTC |
Chen RichardChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 37,500 | $0.00 Strike: $4.75 | $0.00 |
DisclosureSEC source: 0001209191-20-020140 · doc4.xml · derivative · entry 2 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2030-03-16 F2 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 16, 2020. Read SEC document |
| March 16, 2020 Filed Mar 19, 2020 00:44 UTC |
Chen RichardChief Scientific Officer
|
GrantCommon Stock | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-020140 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,500 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest in 16 equal quarterly installments with the first installment vesting on June 16, 2020. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 21:37 UTC |
Chen RichardChief Scientific Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001209191-20-018191 · doc4.xml · derivative · entry 3 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,249 Underlying: Common Stock · 1,000 shares Expires 2022-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 21:37 UTC |
Chen RichardChief Scientific Officer
|
SaleCommon Stock | 1,000 | $7.84 | $7,840.00 |
DisclosureSEC source: 0001209191-20-018191 · doc4.xml · nonDerivative · entry 2 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan by the reporting person. Read SEC document |
| March 09, 2020 Filed Mar 11, 2020 21:37 UTC |
Chen RichardChief Scientific Officer
|
Exercise / conversionCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-018191 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:05 UTC |
Chen RichardChief Scientific Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001209191-20-016310 · doc4.xml · derivative · entry 3 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,249 Underlying: Common Stock · 1,000 shares Expires 2022-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:05 UTC |
Chen RichardChief Scientific Officer
|
SaleCommon stock | 1,000 | $8.76 | $8,760.00 |
DisclosureSEC source: 0001209191-20-016310 · doc4.xml · nonDerivative · entry 2 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan by the reporting person. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:05 UTC |
Chen RichardChief Scientific Officer
|
Exercise / conversionCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-016310 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:40 UTC |
Chen RichardChief Scientific Officer
|
SaleCommon Stock | 101,000 | $8.77 | $885,770.00 |
DisclosureSEC source: 0001209191-20-013622 · doc4.xml · nonDerivative · entry 2 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,000 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan by the reporting person. F2 · price: The weighted average sale price for the transaction reported was $8.77, and the range of prices were between $8.445 and 9.29 per share. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 02:40 UTC |
Chen RichardChief Scientific Officer
|
Exercise / conversionCommon Stock | 101,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-013622 · doc4.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2020 Filed Mar 11, 2020 21:34 UTC Amendment |
Chen RichardChief Scientific Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 101,000 | $0.00 Strike: $0.44 | $0.00 |
DisclosureSEC source: 0001209191-20-018188 · doc4a.xml · derivative · entry 3 Chen Richard · CIK 0001779787 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,249 Underlying: Common Stock · 101,000 shares Expires 2022-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The Shares subject to the option are fully vested and exercisable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.